140 related articles for article (PubMed ID: 37574820)
1. Drugs and bruxism: A study in the World Health Organization's pharmacovigilance database.
Montastruc JL
Br J Clin Pharmacol; 2023 Dec; 89(12):3765-3768. PubMed ID: 37574820
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.
Revet A; Montastruc F; Roussin A; Raynaud JP; Lapeyre-Mestre M; Nguyen TTH
BMC Psychiatry; 2020 Jun; 20(1):308. PubMed ID: 32546134
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: A real-world study using the WHO pharmacovigilance database.
Quilichini JB; Revet A; Garcia P; Bouquié R; Hamard J; Yrondi A; Montastruc F
J Affect Disord; 2022 Jan; 297():189-193. PubMed ID: 34699855
[TBL] [Abstract][Full Text] [Related]
4. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database.
Montastruc JL
Br J Clin Pharmacol; 2024 Jun; 90(6):1525-1528. PubMed ID: 38627211
[TBL] [Abstract][Full Text] [Related]
5. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database.
Gastaldon C; Schoretsanitis G; Arzenton E; Raschi E; Papola D; Ostuzzi G; Moretti U; Seifritz E; Kane JM; Trifirò G; Barbui C
Drug Saf; 2022 Dec; 45(12):1539-1549. PubMed ID: 36400895
[TBL] [Abstract][Full Text] [Related]
6. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
7. Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases.
Humbert X; Fedrizzi S; Chrétien B; Sassier M; Bagheri H; Combret S; Drici MD; Le Bas F; Puddu PE; Alexandre J
Fundam Clin Pharmacol; 2019 Jun; 33(3):296-302. PubMed ID: 30489655
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of QT prolongation with serotonin reuptake inhibitors.
Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
[TBL] [Abstract][Full Text] [Related]
9. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase
Nguyen TTH; Roussin A; Rousseau V; Montastruc JL; Montastruc F
Drug Saf; 2018 Nov; 41(11):1087-1096. PubMed ID: 29956218
[TBL] [Abstract][Full Text] [Related]
10. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Mazhar F; Pozzi M; Gentili M; Scatigna M; Clementi E; Radice S; Carnovale C
CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109
[TBL] [Abstract][Full Text] [Related]
11. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study.
Montastruc JL; Rousseau V; de Canecaude C; Roussin A; Montastruc F
Eur J Clin Pharmacol; 2020 Sep; 76(9):1321-1327. PubMed ID: 32483650
[TBL] [Abstract][Full Text] [Related]
12. Association between haemorrhages and treatment with selective and non-selective serotonergic antidepressants: Possible implications of quantitative signal detection.
Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Muche R; Freudenmann RW; Schönfeldt-Lecuona C
Psychiatry Res; 2015 Sep; 229(1-2):257-63. PubMed ID: 26208982
[TBL] [Abstract][Full Text] [Related]
13. Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database.
Trenque T; Herlem E; Auriche P; Dramé M
Drug Saf; 2011 Dec; 34(12):1161-6. PubMed ID: 22077504
[TBL] [Abstract][Full Text] [Related]
14. Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database.
Gastaldon C; Arzenton E; Raschi E; Spigset O; Papola D; Ostuzzi G; Moretti U; Trifirò G; Barbui C; Schoretsanitis G
Psychol Med; 2023 Sep; 53(12):5645-5653. PubMed ID: 36128628
[TBL] [Abstract][Full Text] [Related]
15. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting.
Trenque T; Maura G; Herlem E; Vallet C; Sole E; Auriche P; Drame M
Drug Saf; 2013 Jul; 36(7):515-9. PubMed ID: 23728950
[TBL] [Abstract][Full Text] [Related]
16. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L
J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
[TBL] [Abstract][Full Text] [Related]
17. Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study.
Montastruc JL; Bura-Rivière A
Eur J Clin Pharmacol; 2024 Feb; 80(2):283-285. PubMed ID: 38112734
[TBL] [Abstract][Full Text] [Related]
18. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.
Pariente A; Daveluy A; Laribière-Bénard A; Miremont-Salame G; Begaud B; Moore N
Drug Saf; 2009; 32(5):441-7. PubMed ID: 19419238
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
20. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.
Montastruc F; Sommet A; Bondon-Guitton E; Durrieu G; Bui E; Bagheri H; Lapeyre-Mestre M; Schmitt L; Montastruc JL
Eur J Clin Pharmacol; 2012 May; 68(5):767-75. PubMed ID: 22116460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
